ECE2015 Eposter Presentations Thyroid (non-cancer) (160 abstracts)
1Department of Endocrinology and Metabolism, Diskapi Yildirim Beyazit Teaching and Research Hospital, Ankara, Turkey; 2Department of Internal Medicine, School of Medicine (Kastamonu), Hacettepe University, Ankara, Turkey.
Introduction: Levothyroxine sodium (LT4) is widely used thyroid hormone to treat hypothyroidism. It is generally recommended to take it in the morning and hungry. Several studies about timing of thyroid hormone administration have shown different effects on TSH and FT4. The aim of this study is to determine the effects of timing of LT4 administration on TSH and the clinical outcomes.
Method: The study group includes 65 patients with primary hypothyroidism who take a minimum dose of 50 mg levothyroxine sodium 30 min before the breakfast. Whether their serum TSH is within the laboratory reference range (0.55.75 mIU/l) has been examined. We have suggested the patients to take LT4 at bed time instead in the morning and the patients have been observed for 3 months. Five patients have been excluded from the study for several reasons. At the end of the study parameters such as TSH, FT4, lipid levels, BMI and clinical outcomes have been evaluated.
Results: Compared to the morning intake, LT4 was taken at bedtime were an increase in free T4 level of 0.06+0.20 (P=0.025) and an increase in body weight of 0.76+1.53 (P<0.001). The TSH levels have shown no significant difference between morning and bedtime intake of LT4 (P>0.05). When the clinical outcomes are evaluated, night sweating in ten patients (% 16.7; P<0.001) and in eight patients (13.3%; P<0.001)) increase in appetite have been observed.
Conclusions: Our study showed that use of LT4 in the morning and at night had similar effects on serum TSH. However, bedtime intake of LT4 has resulted in increase of sweating, appetite and weight.